Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy

Eugenio Stabile; Edouard Cheneau; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; Augusto D Pichard; Lowell F Satler; Ron Waksman

doi:10.1016/j.carrad.2004.11.001

Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy

Cardiovasc Radiat Med. 2004 Oct-Dec;5(4):173-6. doi: 10.1016/j.carrad.2004.11.001.

Authors

Eugenio Stabile¹, Edouard Cheneau, Timothy Kinnaird, William O Suddath, Neil J Weissman, Rebecca Torguson, Kenneth M Kent, Augusto D Pichard, Lowell F Satler, Ron Waksman

Affiliation

¹ Division of Cardiology, Washington Hospital Center, DC 20010, USA.

PMID: 16237987
DOI: 10.1016/j.carrad.2004.11.001

Abstract

Drug-eluting stents, since their approval in the United States, have become the treatment of choice for de novo coronary artery narrowing due to their ability to reduce restenosis and the need for repeat revascularization. We present two patients who underwent percutaneous coronary intervention for the treatment of multivessel coronary artery disease; both patients were treated with sirolimus-eluting stents (SES) and bare metal stents (BMS).

Publication types

Case Reports

MeSH terms

Adult
Angioplasty, Balloon, Coronary
Coronary Artery Disease / therapy*
Coronary Thrombosis / diagnostic imaging
Coronary Thrombosis / etiology*
Humans
Immunosuppressive Agents / administration & dosage
Male
Platelet Aggregation Inhibitors / administration & dosage*
Radiography
Sirolimus / administration & dosage
Stents*
Treatment Refusal
Withholding Treatment*

Substances

Immunosuppressive Agents
Platelet Aggregation Inhibitors
Sirolimus